Evaluation of the diuretic activity of the aqueous and 80% methanol extracts of Ajuga remota Benth (Lamiaceae) leaves in mice by Wubshet Hailu & Ephrem Engidawork
Hailu and Engidawork BMC Complementary and Alternative Medicine 2014, 14:135
http://www.biomedcentral.com/1472-6882/14/135RESEARCH ARTICLE Open AccessEvaluation of the diuretic activity of the aqueous
and 80% methanol extracts of Ajuga remota
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Background: In the Ethiopian traditional medicine, the leaves of Ajuga remota B. (Local name, Armagusa) is used in
the treatment of hypertension. Since this claim has not been investigated scientifically, the aim of the present study
was to evaluate the diuretic potential of the aqueous and 80% methanol extracts of the leaves of Ajuga remota in
mice after acute oral administration.
Methods: Adult mice were administered orally either aqueous (250 mg/kg, AA250; 500 mg/kg, AA500 and 1000 mg/kg,
AA1000) or 80% methanol (250 mg/kg, AM250; 500 mg/kg, AM500 and 750 mg/kg, AM750) extract. Urine output and
electrolyte contents were then quantified up to 5 h and compared with those administered with furosemide 10 mg/kg
(F10) and distilled water (CON).
Results: The larger dose of 80% methanol extract produced significant diuresis (p < 0.01), while the aqueous extract had
shown diuresis both at the middle (p < 0.01) and higher (p < 0.01) doses by the end of the fifth hour compared to CON
mice. Regarding electrolyte excretion, larger doses of both extracts had increased natriuresis (p < 0.001 for AA1000 and p
< 0.01 for AM1000), while the effect on kaliuresis were smaller when compared with the standard, suggesting the plant
could possibly have a potassium-sparing effect. Phytochemical screening revealed the presence of secondary
metabolites like phenolic compounds, tannins, saponins, flavonoids, terpenoids, steroids, and cardiac glycosides, which
might account for the diuretic activity.
Conclusions: The results indicate that the plant is endowed with significant diuretic activity at various doses, providing
evidence for its folkloric use. The major components like flavonoids, tannins, terpenoids and alkaloids found in the plant
might have contributed to the observed diuretic activity.
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Medicinal plants have been known for millennia and are
highly esteemed all over the world as a rich source of
therapeutic agents for the prevention of diseases, and
their health benefits are growing rapidly in recent time.
The reason for this may be that some plants demon-
strate effects comparable to the outcome obtained from
allopathic medicines [1,2]. One of the application areas
of botanicals is their diuretic effect, since there are an
increasing number of plants having such effects. This is
supported by a number of researches published that* Correspondence: ephrem.engidawork@aau.edu.et
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article, unless otherwise stated.evaluated the degree of clinical support for the use of
folklore medicines as diuretics [3-5].
Ajuga remota Benth (Lamiaceae) is an erect rhizoma-
tous pubescent herb that belongs to the genus Ajuga
and growing in the grasslands of Kenya and other parts
of East Africa. In Ethiopia, the vernacular names for the
plant include Armaguusaa (Oromiffa) and it is not ed-
ible to animals, birds or insects. This is probably due to
the very bitter taste of almost all its parts [6].
Several studies are conducted on many species of the
genus Ajuga and their active compounds have been
identified. These efforts have led to the isolation of a
number of compounds, including phytoecdysteroids, neo-
clerodane- diterpines and diterpinoids, triterpines specificd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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anthocyanidin-glucosides and iridoid glycosides, quinols,
withanolid, flavonoids, tannins, triglycerides and essential
oils [7-9].
In East Africa, plants of the genus Ajuga have been used
as a remedy for fever, toothache, dysentery, and high blood
pressure. In North Africa, Ajuga plants are used to treat
diabetes and hypertension, as a panacea (cure-all), specific-
ally for gastrointestinal disorders, and as an anthelmintic
[8]. In Ethiopian folk medicine, Ajuga remota is widely
used traditionally to treat high blood pressure and stom-
ach pain, particularly in Bahirdar Zuria, Amhara region
[10]. Although ample ethnobotanical evidence exists for
the use of Ajuga remota in the treatment of hypertension,
the claim has not been substantiated scientifically. The
present study had therefore attempted to present scientific
data for the biological effects of the plant.Methods
Collection of plant material
The leaves of Ajuga remota were collected from a place
called Sebeta, a few kilometers West of Addis Ababa,
Ethiopia in December 2010. Taxonomic identification
was made by Ato Melaku Wondafrash and a voucher
specimen deposited (Voucher Specimen number WH/001)
at the National Herbarium, College of Natural Sciences,
Addis Ababa University.Experimental animals
Adult male albino mice bred in the animal house of
Ethiopian Health and Nutrition Research Institute with
weights ranging from 25 to 30 g and 8 weeks of age were
used for the experiment. The animals were housed in
polypropylene cages (6–10 animals per cage) under
standard environmental conditions (25 ± 1°C, 55 ± 5%
humidity and 12 h/12 h light/dark cycle). The animals
were allowed free access to tap water and laboratory pel-
let. The care and handling of animals were in accord-
ance with internationally accepted guidelines for use of
animals [11] and the procedure was approved by the
School of Pharmacy Ethics Committee, Addis Ababa
University (IRB/SoP/ 02/03/2010).Extraction of plant material
The leaves of Ajuga remota were sliced to smaller pieces
and dried at room temperature under shade. The dried
and sliced pieces of the leaves were then powdered finely
and subjected to extraction.Figure 1 Thin layer chromatography fingerprint of 80% methanolic
leaf extract of Ajuga remota B. The solvent system is Ethyl acetate:
Toluene (85.5:14.5). A: when the plate is obseved under UV light of
short wavelength (254 nm); B: when observed under UV light of long
wavelength (366 nm).Aqueous extract
Two hundred gram of the dried and powdered leaves of
Ajuga remota was boiled at 100°C in 1000 ml of distilledwater for 30 min, as used traditionally, and cooled to room
temperature for 15 min. The decoction obtained was cen-
trifuged, filtered, and placed in an oven until dried. The
dried aqueous extract was collected and weighed. The ap-
proximate yield of the dry extract was 11.5% (w/w). The
dried plant extract was reconstituted with distilled water
for oral administration.80% methanol extract
Four hundred gram of the leaves of Ajuga remota was
macerated with about 600 ml of 80% methanol for 24 h.
The extract was then filtered and the marc was remacer-
ated twice using the same volume of solvent to exhaust-
ively extract the plant material. The methanol was then
removed from the extract by evaporation under reduced
pressure using a rota vapor (BUCHI Rotavapour R-200,
Switzerland) at 40°C. The resulting dry hydroalcoholic
extract was weighed and calculated for percentage yield,
which was 9.95% (w/w). The dried plant extract was
reconstituted with distilled water for oral administration.
Thin layer chromatography was run to produce a finger-
print of the 80% methanol extract of the leaves of Ajuga
remota and the fingerprint is depicted in Figure 1.Acute toxicity test
Five groups of mice formed and received orally different
doses (350–5000 mg/kg) of the aqueous or hydroalcoholic
extract. The animals were observed for overt toxicities like
diarrhea, weight loss, tremor, lethargy and paralysis
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and then followed for 14 days for any lethality [12].
Grouping and dosing of animals
Animals were randomly assigned into eight groups each
consisting of 8 male mice for diuretic test. Negative con-
trols were treated with the vehicle used for reconstitu-
tion (2 ml/100 g of body weight, CON), according to the
OECD guideline. Positive controls were treated with
standard drug, furosemide 10 mg/kg (F10). Three treat-
ment groups in each test were treated with different
doses of the extract as follows: the aqueous extract with
doses of 250 mg/kg (AA250), 500 mg/kg (AA500), and
1000 mg/kg (AA1000); and hydroalcoholic extract with
doses of 250 mg/kg (AM250), 500 mg/kg (AM500), and
750 mg/kg (AM750). Dose selection was made based on
the acute toxicity test performed prior to commence-
ment of the actual experiment. For the aqueous extract,
one tenth of the limit dose was taken as the middle dose
(500 mg), half of it as the lower dose (250 mg) and twice
of the middle dose as the larger dose (1000 mg). For the
hydroalcoholic extract, the same approach was followed
for the lower and middle dose but 1.5 fold of the middle
dose was set as the larger dose. This was done because
the hydroalcolic extract was positive for many of the sec-
ondary metabolites.
Diuretic activity
Diuretic activity was determined following the methods
used by Lahlou et al. [13], with slight modification. Each
male mouse was placed in an individual metabolic cage
(Metabolic cage for mice, TECHNIPLAST, Italy) 24 h
prior to commencement of the experiment for adapta-
tion and then fasted overnight with free access to water.
The animals were pretreated with physiological saline
(0.9% NaCl) at an oral dose of 0.15 ml/10 g body weight,
to impose a uniform water and salt load [14]. Each
group was then treated as described in grouping and
dosing section orally by gavage. Immediately after ad-
ministration, the mice were individually placed in a
metabolic cage. Urine was then collected and measured
1, 2, 3, 4, and 5 h after dosing. The urine was then filtered
and finally stored at −20°C for electrolyte analyses [15].
The following parameters were calculated in order to
compare the effects of the extracts with vehicle and
standard on urine excretion. The urinary excretion inde-
pendent of the animal weight was calculated as total
urinary output divided by total liquid administered (For-
mula −1). The ratio of urinary excretion in test group to
urinary excretion in the control group was used as a
measure of diuretic action of a given dose of a drug
(Formula −2). A parameter known as diuretic activity
was also calculated. To obtain diuretic activity, thediuretic action of the extract was compared to that of
the standard drug in the test group (Formula – 3) [14].
Formulae




Diuretic Action ¼ Urinary excretion of treatment groups
Urinary excretion of control group
ð2Þ
Diuretic Activity ¼ Diuretic action of test drug
Diuretic action of standard drug
ð3Þ
Analytical procedures
Sodium, potassium and chloride levels of urine and the
plant extract were analyzed. Sodium and potassium con-
centrations were determined by making use of flame
photometry, and chloride concentration was quantified
using Ion Selective Electrode (ISE) analyzer (AVL 9181
Electrolyte Analyzer, Roche, USA). The flame photom-
eter worked by flame production when the atom chan-
ged from its excited state to the ground state, while the
ISE analyzer contains software which permits electrolyte
parameter configuration. A calibration was performed
automatically in both cases prior to analysis with differ-
ent levels of standards. Ratios of electrolytes; Na+/K+
and Cl−/K++Na+ were calculated to evaluate the saluretic
activity of the different extracts. In addition, pH was dir-
ectly determined on fresh urine samples using a pH-
meter. Moreover, the salt content of the extract was also
determined to rule out its contribution on urinary elec-
trolyte concentration.
Phytochemical screening
Phytochemical screening tests were carried out for the
aqueous and 80% methanol extracts of the plant using
standard procedures [16] to identify the presence of sec-
ondary metabolites, including phenolic compounds, tan-
nins, saponins, flavonoids, terpenoids, steroids, alkaloids,
anthraquinones and cardiac glycosides.
Statistical analysis
Data are expressed as mean ± S.E.M (standard error of
mean). Statistical analysis of the data were performed
with one-way analysis of variance (ANOVA) followed by
Tukey’s multiple comparison test. Significant differences
were set at P values lower than 0.05.
Results
Acute toxicity study
Mice were observed for two weeks to see if the aqueous
and hydroalcoholic plant extracts had an acute toxic
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ible signs of toxicity up to the dose of 5 g/kg. This was evi-
denced by absence of tremor, loss of weight, lethargy,
paralysis, stress or adverse behaviors. In addition, there
was also no sign of diarrhea and none of the treated mice
died, suggesting the LD50 is greater than 5000 mg/kg.
Diuretic activity: effect on urine volume
Aqueous extract
The aqueous extract of the plant produced diuresis, which
appeared to be a function of dose (Table 1). The time
course of action of diuresis is also depicted in Figure 2.
AA250 did not produce any detectable difference in urine
volume compared to CON animals at all time points.
AA500 started to increase urine volume from the second
hour, but changes reached statistical significance at the
fourth (68%, p < 0.05) and fifth (93.3%, p < 0.01) hour. By
contrast, the increase in urine volume with the highest
dose (AA1000) was significant (82.2%, p < 0.01) starting
from the very first hour and a maximum increase was
noted at the fifth hour (96%, p < 0.01). F10 treated mice
exhibited a significantly greater urine volume from the
first hour (90%, p < 0.01), which continued until the end of
the fifth hour (95%, p < 0.01). F10 displayed a significantly
greater effect compared to AA250 (p < 0.001) throughout
the time points, but had no significant difference with that
of AA500 from the second hour onwards. Comparable ef-
fects were observed between F10 and AA1000 across all
time points.
Hydroalcoholic extract
No apparent difference was observed between controls and
mice treated with the first two doses (AM250 and AM500)
at all time points. The larger dose (AM750) although re-
sulted in an increased urine volume compared to CON mice
starting from the first hour (38.7%), it failed to reach statis-
tical significance. However, the change became significant atTable 1 Effect of aqueous and 80% methanol extracts of the
Group Volume of urine (ml)
1 h 2 h 3 h
CON 0.62 ± 0.13 0.81 ± 0.11 0.97 ± 0.11 1
F10 1.18 ± 0.07a1 1.46 ± 0.09a3 1.64 ± 0.08a1 1.7
AA250 0.38 ± 0.04b3,c3 0.69 ± 0.05b3,c2 0.98 ± 0.17b2 1.11
AA500 0.56 ± 0.08b3,c2 1.09 ± 0.07 1.41 ± 0.12 1.6
AA1000 1.13 ± 0.13a2,g3,h3 1.26 ± 0.14a1,f3,g3 1.54 ± 0.19a1 1.7
AM250 0.45 ± 0.46b3,c2 0.62 ± 0.07b3 0.68 ± 0.72b3,c2 0.84
AM500 0.48 ± 0.09b3,c1 0.71 ± 0.09b3 0.91 ± 0.12b3 1.08
AM750 0.86 ± 0.03e3,d3 0.98 ± 0.08e3 1.32 ± 0.13 1.5
(n = 8); For aqueous extract: aagainst control, bagainst standard, cagainst AA1000 m
hagainst AM750; For 80% methanol extract aagainst control, bagainst standard, caga
and AM to 80% methanol extract Ajuga remota; F10: Furosemide 10 mg/kg CON: co
activity is considered to be good if it is more than 1.50, moderate if it is 1.00-1.50, lthe fourth hour (57%, p < 0.05), with a maximum effect at
the fifth hour (91.4%, p < 0.01) when compared with the
CON mice (Table 1). F10, on the other hand, produced a
significant increase starting from the first hour.
Both AM250 (p < 0.001) and AM500 (p < 0.01) pro-
duced a lower diuretic effect as compared to that of F10,
while the maximum dose (AM750) had an effect which
was comparable to that of F10 (Table 1).
Saluretic activity: effect on electrolyte content of the urine
Aqueous extract
The urine samples collected over the five hours were ana-
lyzed for the electrolyte content (Na+, K+, and Cl−) and pre-
sented in Table 2. Whilst AA250 tended to decrease
sodium loss by 17.1%, AA500 tended to increase by 34.4%
compared to CON group. By contrast, AA1000 and F10
significantly increased sodium loss by 69.2% (p < 0.001) and
68.9% (p < 0.001), respectively, compared to CON animals.
Urinary K+ excretion was significantly higher with F10
(106.8%, p < 0.001) compared to CON group. AA250
and AA500 tended to increase kaliuresis by 31.6% and
66.7%, respectively, which was not statistically significant
compared to CON mice. The larger dose of the aqueous
extract, on the other hand, reduced K+ loss by 8.8%
compared to controls, but the decrease was significant
(41.4%, p < 0.001) when compared to F10. In the case of
Cl− excretion, though treatment tended to increase loss
of the anion compared to CON mice, the increase
reached statistical significance only with AA1000 (88.6%,
p < 0.001).
Hydroalcoholic extract
The urinary Na+ excretion inclined to exhibit an increas-
ing pattern with dose, as it was 6.3%, 50.7% and 69.6%
(p < 0.01) for AM250, AM500 and AM750, respectively,
when compared to CON group (Table 2). On the other
hand, K+ excretion had insignificantly increased fromleaves of Ajuga remota on 5 h urine volume in mice
Diuretic action Diuretic activity
4 h 5 h
.0 ± 0.11 1.05 ± 0.10 1.0
9 ± 0.09a2 2.05 ± 0.11a2 1.95 1.0
± 0.18b2,c1 1.16 ± 0.17b3,c2,d1 1.10 0.56
8 ± 0.13a1 2.03 ± 0.13a2 1.93 0.99
3 ± 0.17a2 2.06 ± 0.20a2 1.96 1.01
± 0.07b3,c2 1.1 ± 0.85b3,c3 1.06 0.54
± 0.13b2,c1 1.31 ± 0.11b2,c2 1.25 0.64
7 ± 0.16a1 2.01 ± 0.19a2 1.92 0.98
g/kg, dagainst AA500 mg/kg, eagainst AA250, fagainst AM250, gagainst AM500,
inst AM750 mg/kg; 1p < 0.05, 2p < 0.01, 3p < 0.001; AA refers to aqueous extract
ntrols treated with distilled water; Numbers refer dose in mg/kg; Diuretic



























Figure 2 Time course of diuresis in mice treated with different
doses of aqueous extract of the leaves of Ajuga remota: n = 8,
AA250 - 250 mg/kg, AA500 - 500 mg/kg, and AA1000 - 1000 mg/kg
of aqueous extract of Ajuga remota; F10- Furosemide 10 mg/kg,
CON – group that received distilled water.
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level, albeit insignificantly, with AM750. The excretion
profile of Cl− had also increased by 26.1%, 28.6%, and
76% (p < 0.05) for AM250, AM500 and AM750, respect-
ively (Table 2).
Na+ loss produced by F10 was significantly greater
compared to CON (p < 0.001) and AM250 (p < 0.05), but
no apparent difference was noted when compared to
AM500 and AM750 groups. K+ excretion, however, ap-
peared to be insignificantly higher with the lower and
middle dose of the extract, but lower with the highest
dose used in this study compared to F10 mice. In
addition, no apparent difference was observed in Cl−
excretion between the standard and all doses of the
extract.
Electrolyte content of the extract
Water soluble salts could be present in the extract and
subsequently interfere with the urinary excretion ofTable 2 Effect of aqueous and 80% methanol extracts of the
excretion in mice
Group Urinary electrolyte concentration (mmol/L)
Na+ K+ Cl−
DW 59.97 ± 7.83 43.7 ± 5.80 44.2 ± 2.58
F10 101.3 ± 6.01a3 92.07 ± 13.85a3 73.85 ± 11.27
AA250 49.70 ± 2.74b3,c3 57.5 ± 5.94b1 50.87 ± 10.58
AA500 80.62 ± 4.89 72.85 ± 2.66c1 58.75 ± 8.34
AA1000 101.5 ± 6.98a3 38.08 ± 1.81b3 83.37 ± 2.71a3
AM250 63.75 ± 7.3b1,d1 97.5 ± 13.2c1 55.74 ± 6.23
AM500 90.37 ± 5.8a1,e1 100.6 ± 11.7c2 56.82 ± 8.06
AM750 101.7 ± 4.72a2,e2 53.5 ± 2.95 77.78 ± 9.71a1
(n = 8); For aqueous extract aagainst control, bagainst standard, cagainst AA1000 mg
AM750 mg/kg, dagainst AM500 mg/kg, eagainst AM250 mg/kg; 1p < 0.05, 2p < 0.01,
of control group; AA refers to aqueous extract and AM to 80% methanol extract of Ajug
Numbers refer dose in mg/kg.electrolytes. The content of Na+, K+ and Cl− in both ex-
tracts was therefore determined to exclude this possibil-
ity. The result revealed that Na+ and Cl− were not
detectable at all doses in the extracts as tested by the
instrument used in the present study. K + content of
the aqueous extract was found to be 35.3, 40.7 and
47.1 mmol/l for AA250, AA500 and AA1000, respect-
ively. In case of 80% methanol extract, values as low as
12, 20 and 23.5 mmol/l was detected for AM250,
AM500 and AM750, respectively.
Urinary pH
Urinary pH measurement revealed that the different
treatment groups of both aqueous and 80% methanol
extracts had produced relatively alkaline urine. The pH
of urine treated with the aqueous extract had shown an
increase from AA250 (7.57) to AA1000 (7.72). The CON
group produced the lowest pH and the standard group
an intermediate pH (7.45) between vehicle and extract
treated groups (Figure 3). Treatment with the hydroalco-
holic extract increased pH from 7.3 (AM250) to 7.88
(AM750). Urinary pH of CON and F10 was higher
than the lowest doses but lower than the other doses
(Figure 4).
Phytochemical screening
Both extracts of Ajuga remota were explored for the
composition of medicinally active compounds and both
were found to be positive for phenolic compounds,
saponins, steroids, cardiac glycosides, flavonoids, tannins
and terpenoids. On the other hand, alkaloids and anthra-
quinones were only found in the hydroalcoholic extract.
Discussion
Diuretic activity may be very useful in a number of con-
ditions like hypertension, hypercalciuria, and cirrhosis ofleaves of Ajuga remota on 5 h urinary electrolyte
Saluretic index Na+/K+ Cl−/ Na++K+
Na+ K+ Cl−
1.37 0.43
1.68 2.1 1.67 1.10 0.38
0.83 1.32 1.13 0.86 0.47
1.34 1.67 1.33 1.11 0.38
1.69 0.87 1.87 2.66 0.59
1.06 2.23 1.26 0.65 0.34
1.51 2.30 1.29 0.89 0.29
1.69 1.22 1.76 1.90 0.50
/kg; For 80% methanol extract, aagainst control, bagainst standard, cagainst
3p < 0.001; Saluretic Index =mmol of electrolyte of test group/mmol of electrolyte












CON AA250 AA500 AA1000 F10
Figure 3 Urinary pH of mice treated with aqueous extract of the
leaves of Ajuga remota: AA250- 250 mg/kg, AA500- 500 mg/kg,
and AA1000- 1000 mg/kg of aqueous extract of Ajuga remota;
F10- Furosemide 10 mg/kg, CON –group that received distilled water.
Hailu and Engidawork BMC Complementary and Alternative Medicine 2014, 14:135 Page 6 of 8
http://www.biomedcentral.com/1472-6882/14/135liver. Since diuretics are employed clinically in the treat-
ment of edema, it would be highly important to demon-
strate effectiveness in the presence of electrolyte and
water [17]. Thus, it is presumed to be advantageous to
‘pre-treat’ or ‘prime’ the test animals with various fluids
in screening agents for potential diuretic activity.
The aqueous and 80% methanol extracts of the leaves
of Ajuga remota showed an increase in urine volume
that appeared to vary with dose and time as well as the
nature of the extract. Compared to the 80% mehanol
extract, the aqueous extract produced a better diuretic
effect, particularly with increasing dose in the early
hours (p < 0.05 for AA1000 vs. AM250, AM500, &
AM7500) (Table 1). The lower doses of both extracts
did not produce an appreciable effect, but, whilst the
medium dose of the aqueous extract was able to produce
significant effect beginning from the fourth hour, the
same dose of the 80% extract was devoid of any effect








CON AM250 AM500 AM750 F10
Figure 4 Urinary pH of mice treated with 80% methanol extract of
the leaves Ajuga remota: AM 250–250 mg/kg, AM 500–500 mg/
kg, and AM 1000–1000 mg/kg of 80% methanol extract of
Ajuga remota; F10- Furosemide 10 mg/kg, CON –group that
received distilled water.probably suggest that the lower doses might represent
subthreshold doses. The higher dose of both the aque-
ous and 80% methanol extracts produced comparable ef-
fect to that of furosemide. Even better effect was
observed with the aqueous extract, as it had a diuretic
activity even more than the standard drug. It is therefore
possible to suggest that the ingredient (s) of the plant
material responsible for increasing urine output could
probably be polar and hence better extracted in water
than 80% methanol.
The diuretic activity of the extracts of Ajuga remota at
their higher respective doses was a moderate type for the
aqueous and mild for the hydroalcoholic extract, since
their values were 1.01 and 0.98 for AA1000 and AM750,
respectively. Diuretic activity is considered to be good if it
is more than 1.50, moderate if it is 1.00-1.50, little if it is
between 0.72-1.00 and nil if it less than 0.72 [18].
The effect of the extracts on water excretion was ac-
companied by urinary electrolyte excretion effect, since
there appeared to be an increased salt excretion as com-
pared to the control group, which supports the idea that
the diuretic effect of Ajuga remota was of the saluretic
type in contrast to aquaretic type, which is a typical fea-
ture of most phytodiuretic agents [19]. The larger doses
of both extracts did have an interesting natriuretic effect
and thus could have a beneficial effect in different
edematous conditions. The ratio Na+/K+ was calculated as
indicator of natriuretic activity and resulted in values of
2.66, 1.90 and 1.1 for AA1000, AM750, and F10 respect-
ively. This indicates that the extracts increase sodium ex-
cretion more than potassium, which is considered as a
very good safety profile of diuretic agents, as hypokalemia
is one of the potential adverse effects of synthetic di-
uretics, such as furosemide.
In contrast to previous studies of aqueous and metha-
nol extracts of some plants which showed an interesting
K+-saving effect at low and intermediate doses [19], in
the present study this effect was observed at the higher
doses. It is probable that at low dosages of the aqueous
and methanol extracts of Ajuga remota, the substances
responsible for K+- sparing effect might not reach suffi-
cient concentration to exert the effect. On the other hand,
aqueous and 80% methanol extracts of some plants such
as Rumex abyssinicus J. have been demonstrated to be de-
void of K+- sparing effect [5]. These observations point to
the fact that there are at least two different mechanisms
by which diuersis could be achieved, one of which pro-
duces notable diuresis with a sparing of potassium and an-
other with very strong diuresis in which there is a clear
tendency to lose the K+ - conservative effect [20].
Moreover, onset of the diuretic action of AA1000 was
sufficiently rapid and had a fairly long duration of action as
it produced significant effect from the first hour (p < 0.01)
to the fifth hour (p < 0.01) of the experiment. This is an
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of administration. This coupled to the little or no risk of
hypokalemia makes the extract a potential herb worth in-
vestigating for treatment of edematous conditions.
It is possible that Ajuga remota extracts exerted diur-
etic effect by inhibiting tubular reabsorption of water
and electrolytes, since such action has been suggested
for some other plants. The possibility of direct action of
potassium content of the plant extract on diuretic effect
could be excluded, since the K+ content of the extract
was very low in comparison with the salt concentration
obtained from other plants [21].
Loop diuretics like furosemide increase urinary flow
rate and urinary excretion of sodium, potassium and
chloride by inhibiting Na+–K+–2Cl− symporter in the
thick ascending loop and by inhibiting carbonic anhy-
drase enzyme. The larger doses of aqueous and 80%
methanol extracts of Ajuga remota used in the present
study produced similar Na+ and Cl− excretion profile to
that of furosemide. However, there is a difference be-
tween the extracts and the standard when K+ excretion
is considered. This could possibly suggest that the mech-
anism by which the extract produces diuresis is not
exactly the same to that of loop diuretics. It is also pos-
sible to exclude the thiazide-like type of mechanism ei-
ther, as the extracts, depending on dose, relatively
increased the urinary K+ level more and alter the urinary
Na+/K+ ratio.
The Cl−/ Na++K+ ratio was calculated and shows the
extent of carbonic anhydrase inhibitory effect. Carbonic
anhydrase inhibition can be excluded at ratios between
0.8 and 1.0 and with decreasing ratios; slight to strong
inhibition can be assumed [11]. The Cl−/ Na++K+ ratio
was calculated for both extracts and the intermediate
doses, AA500 and AM500, showed the strongest inhibi-
tory effect with values of 0.38 and 0.29, respectively.
Thus, it appears likely that the strongest carbonic anhy-
drase inhibition effect at these middle doses might have
contributed to the highest K+ loss compared to the other
doses. Hence, it is plausible to assume that one of the
possible mechanisms of action of these extracts could be
carbonic anhydrase inhibition.
In determination of urinary pH, the extracts showed a
relative increase in pH values as compared to controls, re-
inforcing the notion that carbonic anhydrase inhibition as
one of the possible mechanism of action of the plant. In
addition, the reduction of potassium excretion at the max-
imum doses of the extracts along with the resulted alkalin-
ization of urine might give a clue on the possibility of the
plant acting as a modest potassium-saving diuretic.
The exact nature of the active principle/s responsible
for the diuretic effects of the hydroalcoholic and aque-
ous extracts of the plant is/are, so far, not known. How-
ever, preliminary phytochemical analysis carried out withboth extracts revealed the presence of bioactive mole-
cules, including flavonoids and steroids. Previous studies
have demonstrated that there are several compounds
which could be responsible for the plants diuretic effects
such as flavonoids, saponins or organic acids [22]. The
effect may be produced by stimulating regional blood
flow or initial vasodilatation, or by producing inhibition
of tubular reabsorption of water and anions, with the re-
sult in both cases being diuresis [20].
Conclusions
Collectively, these observations provide evidence for the
ethnomedical use of Ajuga remota for treatment of hyper-
tension largely through enhancement of salt and water ex-
cretion. Although the active components (s) for the
observed effect remain (s) to be seen, polar constituents
singly or in synergy act by multiple mechanisms to pro-
duce the observed effect. Indeed, multiple mode of action
had been reported with some herbal medications [23].
Looking at the data, the larger doses, particularly of
the aqueous extract produced a very interesting profile,
which was comparable to the loop diuretics. The safety
profile of the extract is an added advantage that calls for
conducting further research to ascertain the findings re-
ported in this study.
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